Queen's University

American Battery Technology Company Hires Former Tesla Head of FP&A Europe, Scott Smith, as Vice President of Financial Planning and Analysis

Retrieved on: 
Tuesday, April 30, 2024
University, ABTC, Smith School, Frito-Lay, PepsiCo, Commerce, FP&A, Business, Forecasting, ABAT, Smith, Queen's University, Queen, FP, Recycling, American Battery Technology Company, Growth, Strategic planning, Management

RENO, Nev., April 30, 2024 /PRNewswire/ -- American Battery Technology Company (ABTC) (NASDAQ: ABAT), an integrated critical battery materials company that is commercializing its technologies for both primary battery minerals manufacturing and secondary minerals lithium-ion battery recycling, is pleased to announce the onboarding of Scott Smith as its vice president of financial planning and analysis (FP&A) to support the company's strategic growth trajectory and to lead the company's investor relations functions.

Key Points: 
  • Smith is an experienced finance professional with over a decade of expertise in financial business operations within the electric vehicle and consumer goods sectors.
  • He is skilled in strategic planning, intricate financial modeling, and fostering cross-functional partnerships with demonstrated success in enhancing cost efficiencies, facilitating market expansion, and maximizing investment returns.
  • "I am thrilled to join American Battery Technology Company to help support the company's rapid growth and to work with our strategic partners to facilitate our capital expansion projects," stated Scott Smith, ABTC's vice president of financial planning and analysis.
  • Smith earned a bachelor's in commerce from the Smith School of Business at Queen's University in Kingston Ontario.

Mitel Appoints Bill Dunnion as Chief Information Security Officer

Retrieved on: 
Thursday, April 18, 2024
VoIP, Software, Carriers and Services, Mobile, Wireless, Networks, Internet, Hardware, Apps, Applications, Technology, Security, Other Technology, Telecommunications, Unify, Organization, University, CISO, ISO, Dunnion, Risk management, Bell Canada, Queen's University, Multimedia, Confidentiality, NIST

Mitel®, a global leader in business communications, today announced the appointment of Bill Dunnion as Chief Information Security Officer (CISO).

Key Points: 
  • Mitel®, a global leader in business communications, today announced the appointment of Bill Dunnion as Chief Information Security Officer (CISO).
  • Dunnion will oversee Mitel’s information security strategy, security architecture, and security standards compliance.
  • View the full release here: https://www.businesswire.com/news/home/20240418221102/en/
    Bill Dunnion, Chief Information Security Officer (CISO) at Mitel.
  • “Security is at the forefront of everything we do at Mitel,” said Jamshid Rezaei, Chief Information Officer at Mitel.

Strengthening Canadian research and innovation

Retrieved on: 
Friday, April 19, 2024
Education, University, Ecosystem, Investment, Physics, First Nations, Vaccine, AI, Housing, Parent, Research, Artificial intelligence, House, Generation Z, Federation, Science, Pandemic, Queen's University, Canadian Light Source, Queen, Commons, Drug development, TRIUMF, Student, Government, CANARIE, Organization, Growth

The Prime Minister, Justin Trudeau, today highlighted an over $4.6 billion package of measures from Budget 2024 to strengthen Canadian research and innovation.

Key Points: 
  • The Prime Minister, Justin Trudeau, today highlighted an over $4.6 billion package of measures from Budget 2024 to strengthen Canadian research and innovation.
  • Providing $2.6 billion in core research grant funding, scholarships, and fellowships to support our researchers and their ground-breaking discoveries:
    This includes $1.8 billion in core research grant funding for a 30 per cent increase over five years of Canada's core research grant programs that support faculty-led research projects.
  • To provide better co-ordination across the federally funded research ecosystem, we will bring together our three research funding organizations within a single new capstone research funding organization.
  • That's why Budget 2024 supports Canadian researchers at the forefront of discovery and innovation as they continue to position Canada as a global leader in science research.

Dr. Wisdom Tettey Appointed Carleton University's 17th President and Vice-Chancellor

Retrieved on: 
Tuesday, April 16, 2024
World Bank, United Nations, Forum, Learning, Science, Publication, Teaching, Creative, Research, Theory, Communication, Chancellor (education), International Association, Queen's University, Queen, Interim, CivicAction, Faculty, Community, Culture, Medical device

Wisdom Tettey has been appointed Carleton University's 17th President and Vice-Chancellor.

Key Points: 
  • Wisdom Tettey has been appointed Carleton University's 17th President and Vice-Chancellor.
  • The appointment of Dr. Tettey follows an international search process that engaged hundreds of internal and external constituents.
  • "I am delighted to welcome Dr. Tettey to Carleton," said Greg Farrell, chair of the Board of Governors.
  • "Carleton is a highly regarded university that is leveraging its accomplishments to propel itself to global leadership," said Dr. Tettey.

Aviceda Therapeutics Announces Formation of Renowned European Clinical Advisory Board

Retrieved on: 
Monday, April 8, 2024
Technology, Research, Nanotechnology, Clinical Trials, Biotechnology, Health, Pharmaceutical, Optical, Science, Faculty, Medical University of Vienna, Part, Patient, Queen's University, Optometry, Queen's University Belfast, CAB, MD, Royal Victoria Hospital, Laborie (company), Medical school, Therapy, Retina, Safety, AMD, Geographic atrophy, Pharmaceutical industry

Aviceda Therapeutics , a private clinical-stage biotech company focused on developing next-generation immunomodulators by harnessing the power of glycobiology to alleviate chronic, non-resolving inflammation, announced today the formation of its European Clinical Advisory Board (CAB) made up of top internationally recognized thought leaders in retina to provide strategic consultation on the company’s clinical development of its lead asset, AVD-104, for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Key Points: 
  • Aviceda Therapeutics , a private clinical-stage biotech company focused on developing next-generation immunomodulators by harnessing the power of glycobiology to alleviate chronic, non-resolving inflammation, announced today the formation of its European Clinical Advisory Board (CAB) made up of top internationally recognized thought leaders in retina to provide strategic consultation on the company’s clinical development of its lead asset, AVD-104, for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
  • The Company also announced that Tarek S. Hassan, MD will serve as Chair of the European and US CABs.
  • “We are excited that results from Part 1 of the US Phase 2/3 SIGLEC trial demonstrated functional and anatomic improvement in eyes with GA secondary to AMD after a single injection of AVD-104,” said Mohamed Genead, M.D., Aviceda’s Co-founder and CEO.
  • “With the contributions and support of this esteemed panel—and with Dr. Hassan as its chair—we look forward to bringing our clinical efforts to Europe later this year.”

Visionary Holdings Inc. Announces Board Change

Retrieved on: 
Thursday, April 4, 2024
Canadian Pharmacists Journal, GV, Void coefficient, The Company, CHG, Kealey, Canada India Foundation, Public policy, Artificial intelligence, AECL, Pharmacist, University, Queen's University, Pharmacy, Pharmacy school, Kent State University, School

The Company's board of directors (the "Board") elected Mr. Marc Kealey as the Company's Vice Chairman of the Board of Directors and a member of the Board.

Key Points: 
  • The Company's board of directors (the "Board") elected Mr. Marc Kealey as the Company's Vice Chairman of the Board of Directors and a member of the Board.
  • Mr. Kealey has served as the Chairman of the Board since November 2022 to June 2023.
  • The Board has determined that Mr. Kealey qualifies as an "Independent Director" within the meaning of Nasdaq Rule 5605.
  • Following Mr. Kealey's appointment, the Board of the Company is comprised of five (5) directors, including four (4) independent directors.

Alexion Canada Appoints Karen Heim as New General Manager

Retrieved on: 
Tuesday, April 2, 2024
Circulatory system, Neurology, AstraZeneca, GSK plc, Metabolism, Hematology, Cardiology, Patient, DSM-IV codes, Research, Alexion Pharmaceuticals, Bachelor of Science, Acquisition, University, Senior, Metallurgy, Nephrology, Queen's University, Rare disease, Immunity (medical), Alexion, Ophthalmology, Pharmaceutical industry

MISSISSAUGA, ON, April 2, 2024 /CNW/ - Alexion Pharma Canada Corp., AstraZeneca's Rare Disease group, is pleased to announce the appointment of Karen Heim as Vice President and General Manager, Canada, effective April 1st, 2024.

Key Points: 
  • MISSISSAUGA, ON, April 2, 2024 /CNW/ - Alexion Pharma Canada Corp., AstraZeneca's Rare Disease group, is pleased to announce the appointment of Karen Heim as Vice President and General Manager, Canada, effective April 1st, 2024.
  • In this role, Ms. Heim will lead the Canadian affiliate in its unwavering commitment to helping people affected by rare diseases live longer, healthier lives.
  • "Karen's deep healthcare experience and incredible passion make her the perfect fit to lead this mission in Canada and drive it with expertise and ambition."
  • "Taking on this leadership role at Alexion Canada as it continues to grow, with a focus on research and innovation, is incredibly exciting," says Ms. Heim.

Sun Life names Timothy Deacon as Chief Financial Officer

Retrieved on: 
Monday, March 25, 2024
Certified Public Accountant, Financial management, TIM, Sun, Growth, Sun Life Financial, CFO, Business, Chartered, University, Treasurer, Commerce, Capital market, TSX, Senior, Queen's University, Sustainability, SLF, FCPA, CPA Canada, St. Clement's School, School, Management

TORONTO, March 25, 2024 /PRNewswire/ - Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) is pleased to announce the appointment of Timothy (Tim) Deacon as Executive Vice-President and Chief Financial Officer, reporting to Kevin Strain, President and CEO, Sun Life, effective April 8, 2024.

Key Points: 
  • TORONTO, March 25, 2024 /PRNewswire/ - Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) is pleased to announce the appointment of Timothy (Tim) Deacon as Executive Vice-President and Chief Financial Officer, reporting to Kevin Strain, President and CEO, Sun Life, effective April 8, 2024.
  • Mr. Singh will continue in his role as President of Sun Life Asia and as CFO until Mr. Deacon assumes his new role.
  • Mr. Deacon joins Sun Life most recently from a large pension plan with an extensive global footprint where he was the Chief Financial Officer and led a global finance function including financial management and reporting, taxation, financial operations, enterprise planning, asset valuation, procurement and sustainability reporting.
  • As CFO, Mr. Deacon will have responsibility for Sun Life's Finance organization including Finance, Tax, Capital Management, Investor Relations and strategic financial initiatives.

Laconic Appoints Nicola von Schroeter to Head up Strategic Alliances

Retrieved on: 
Monday, March 18, 2024
Carbon, Honor, Organization, Entrepreneurship, Partnership, SVP, Capilano University, Management, University, Head, NCM, IIROC, Senior, NDC, Morgan Stanley, Queen's University, Patent, Data management, CanDeal, Cryptocurrency

CHICAGO, March 18, 2024 /PRNewswire/ -- Laconic Infrastructure Partners Inc. (Laconic), announced that Nicola von Schroeter will lead Laconic's partner program as Senior Vice-President of Strategic Alliances.

Key Points: 
  • CHICAGO, March 18, 2024 /PRNewswire/ -- Laconic Infrastructure Partners Inc. ( Laconic ), announced that Nicola von Schroeter will lead Laconic's partner program as Senior Vice-President of Strategic Alliances.
  • In her position as SVP Strategic Alliances, Ms. von Schroeter will play a key role in building relationships with strategic players operating in the carbon market ecosystem.
  • "Since working with Laconic's leadership team to define this strategy, it is the right time for the deployment of financial markets infrastructure through collaborative initiatives to help Paris member nations achieve their NDC goals," said Nicola von Schroeter, SVP of Strategic Alliances, Laconic.
  • Prior to Laconic, Ms. von Schroeter provided strategic consulting services to CEOs of fintech startups.

Beanfield welcomes new SVP, Commercial Services, Chris Adamkowski

Retrieved on: 
Thursday, March 7, 2024
Cloud, Google Cloud, Angel investor, Entrepreneurship, DEI, AI, SVP, Growth, MBA, Queen's University, Fintech, University, OMERS, Management

Chris Adamkowski comes to Beanfield with a wealth of scaling experience, including more than a decade in senior leadership roles at Google and Google Cloud.

Key Points: 
  • Chris Adamkowski comes to Beanfield with a wealth of scaling experience, including more than a decade in senior leadership roles at Google and Google Cloud.
  • With an MBA from Queen's University, Mr. Adamkowski is passionate about entrepreneurship, DEI, and helping Canadian businesses grow.
  • Dan Armstrong, CEO and Founder of Beanfield, said, “We are thrilled to have Chris join the Beanfield team.
  • “I am thrilled to be joining Beanfield and contributing to the mission of connecting communities through Canada's largest privately owned fibre-optic network.